Nota: La página que ha solicitado no está en su idioma predeterminado. Usted está usando nuestra plataforma en otro idioma ahora.

Novartis's biggest sales growth drivers by change in sales 2019-2026

Published by
Matej Mikulic,
Jul 20, 2020
Inclisiran is expected to be one of the biggest sales growth drivers for Novartis with a total predicted change in sales of 2.22 billion U.S. dollars between 2019 and 2026. In the course of the COVID-19 pandemic, many pharma projects not related to SARS CoV-2 got delayed. On the other hand, drug approval agencies - like the FDA in the U.S. - are also focused on approvals of products related to the pandemic.

Novartis's projected top sales growth drivers from 2019 to 2026 (in million U.S. dollars)

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

June 2020

Region

Worldwide

Survey time period

as of June 2020

Citation formats
Use Statista now: Unlimited Access to All Statistics! $199 USD / Month
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$199 USD / Month *
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " Top pharmaceutical drugs "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Top pharmaceutical drugs

Global overview

3

Top companies' top products

5

Best-selling drugs

7

U.S. overview

5

Outlook

5

Further related statistics

11

Further Content: You might find this interesting as well

Statistics

Topics

Biotech drugsGlobal pharmaceutical industryCancer in the U.S.AmgenCoronavirus (COVID-19) vaccines and treatments
All features, all contents, at all times: Learn more about our professional solutions.
Learn more about how Statista can support your business.
Menu